Study for Novel Coronavirus Pneumonia (NCP)

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2,000 enrolled

Overview

To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

By retrospectively analyzing the clinical epidemiological characteristics of the novel coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth analyzing the disease development process and outcome trends of NCP patients to develop practical and effective clinical diagnosis and treatment schemes and provide guarantee for the rapid control of the epidemic.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Novel Coronavirus Pneumonia

Interventions

systemic treatmentCOMBINATION_PRODUCT

Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial Version 5)"; Exclusion Criteria: * Physician judged the patient was not suitable for this clinical trial.

Locations (1)

Union hospital

Wuhan, Hubei, China

RECRUITING

Outcomes

Primary Outcomes

recovery

Number of patients recover from novel coronavirus pneumonia

Time frame: up to 24 weeks

Central Contacts

Yang Jin

CONTACT

13554361146 whunjy@126.com

Jiancai Wu

CONTACT

02785726685

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.